sur OXURION (EBR:OXUR)
Oxurion Publishes its 2025 Annual Report
Leuven, Belgium – Oxurion NV, a Belgian pharmaceutical company listed on Euronext Brussels, has released its annual report for the financial year ending December 31, 2025. This document is available in the "Investors" section of their website and can be downloaded in PDF format.
Simultaneously, Oxurion convened its Annual General Meeting of Shareholders, details of which are available on its dedicated web portal. Oxurion, which specializes in acquiring majority stakes in European pharmaceutical subcontractors, seeks to build an integrated group focused on the healthcare sector.
Certain forward-looking statements in the press release refer to risks and uncertainties. The company cautions that future results may differ from current expectations.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OXURION